pembrolizumab 100 mg / 4 mL (INJECTION)
|
$3120.5825
|
|
AUS PBS
|
generic
|
Keytruda (1) |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
pembrolizumab 25 mg / 1 mL (1 mL INJECTION)
|
$3569.3400
|
|
VA Big4
|
|
KEYTRUDA (1) |
Merck Sharp & Dohme Corporation |
|
pembrolizumab 25 mg / 1 mL (1 mL INJECTION)
|
$3619.2550
|
|
VA Big4
|
|
KEYTRUDA (2) |
Merck Sharp & Dohme Corporation |
|
pembrolizumab 25 mg / 1 mL (1 mL INJECTION)
|
$4721.6200
|
|
VA FSS
|
|
KEYTRUDA (1) |
Merck Sharp & Dohme Corporation |
|
pembrolizumab 25 mg / 1 mL (1 mL INJECTION)
|
$4792.4300
|
|
VA FSS
|
|
KEYTRUDA (2) |
Merck Sharp & Dohme Corporation |
|